Biotech Gwth Share News (BIOG)

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

Shire Chairman sells shares following 'excellent' 2013 results

Shire's Chairman, Matthew Emmens, has sold 36,100 shares in the biopharmaceutical company following its 'excellent' results for 2013. Emmens disposed of the shares at 3,314.85p each for a total of just under £1.2m shares. After a pick-up in earnings growth in the fourth quarter, the group beat f

Biotech Growth Trust Beats Benchmark On Holdings In Fluidigm And Incyte

LONDON (Alliance News) - The Biotech Growth Trust PLC Wednesday said its net asset value rise beat that of its benchmark in the final three months of 2013 as its holdings in Fluidigm and Incyte paid off, but has since lost a bit of ground. Net asset value rose by 8.2% in the three months to

Rolls Royce director makes sale

The President and Chief Executive Officer of Rolls-Royce North America, James Guyette, was once again seen selling shares, this time following the vesting of shares awarded under the company's performance share plan. Guyette was awarded 137,075 shares and subsequently sold 55,900 of them, earning £

Chariot Chairman buys 100,000 shares

Co-founder and Non-Executive Chairman of Chariot Oil and Gas, an Africa-focused exploration company, Adonis Pouroulis, has scooped up 100,000 shares in the firm. He made the purchase on Tuesday, the same day the company admitted that the Tapir South well (1811/5-1), offhore Namibia, failed to find

Instem acquires BioWisdom

Healthcare IT services provider Instem Life Sciences is buying Cambridge-based BioWisdom, which supplies software to analyse R&D-related healthcare data. AIM-quoted Instem is paying an initial enterprise value of £900,000, although that figure could increase to £1.5m depending on performance in 20

Biotech Growth Trust NAV 182.6P At March 31

LONDON (Dow Jones)--The Biotech Growth Trust PLC (BIOG.LN) said Wednesday its net asset value per share at March 31 was 182.6 pence (March 31, 2009: 136.9 pence) -NASDAQ Biotechnology Index 618.1 (2009: 477.5) -Shareholders' funds GBP120.4 million (2009: GBP70.2 million) -During the full

Edinburgh chairman splashes out

Scott Dobbie, chairman of Edinburgh Investment Trust, has made a significant addition to his personal holding in the Invesco-managed trust. Dobbie, who also chairs the Securities & Investment Institute, bought a further 80,000 ordinary shares this week at a cost of £266,400 to take his stake to mo